BB
CRL icon

Bell Bank’s Charles River Laboratories CRL Stock Holding History

Bell Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,241
Closed -$256K – 181
2024
Q2 		$256K Sell
1,241
-260
-17% -$58.9K 0.02% 172
2024
Q1 		$407K Sell
1,501
-215
-13% -$51.3K 0.04% 150
2023
Q4 		$406K Sell
1,716
-146
-8% -$28.7K 0.04% 141
2023
Q3 		$365K Sell
1,862
-81
-4% -$16.6K 0.04% 146
2023
Q2 		$409K Sell
1,943
-82
-4% -$16.3K 0.04% 141
2023
Q1 		$409K Sell
2,025
-87
-4% -$19.7K 0.04% 139
2022
Q4 		$460K Sell
2,112
-26
-1% -$5.68K 0.05% 135
2022
Q3 		$421K Sell
2,138
-40
-2% -$8.63K 0.05% 133
2022
Q2 		$466K Buy
2,178
+171
+9% +$41.8K 0.06% 137
2022
Q1 		$570K Buy
+2,007
New +$619K 0.06% 119

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bell Bank's CRL Position: Q3 2024 in Review

Bell Bank sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 1,241 shares — an estimated $256K sold.

Bell Bank first reported a position in CRL in Q1 2022 and held it in 10 quarters. The position peaked at $570K in Q1 2022. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Bell Bank reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • Bell Bank sold 1,241 Charles River Laboratories shares in Q3 2024, an estimated $256K.
  • Bell Bank first reported a position in Charles River Laboratories in Q1 2022 and held it in 10 quarters.
  • Bell Bank's Charles River Laboratories position peaked at $570K in Q1 2022.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Bell Bank's 13F filing for Q3 2024, filed 6 Nov 2024.